Husillos-Alonso Adrián, Herranz Amo Felipe, Subirá-Ríos David, Díez-Cordero José María, Moralejo-Gárate Mercedes, López-López Esther, Piñero-Sánchez Javier, Ogaya Pinies Gabriel, Lledó-García Enrique, Hernández-Fernández Carlos
Servicio de Urologia.Hospital General Universitario Gregorio Marañon. Madrid.Spain.
Arch Esp Urol. 2013 Oct;66(8):787-95.
To identify risk factors for progression in patients with invasive bladder carcinoma who were pT0/pT1/pTa after cystectomy.
We analyzed the clinical records of 97 post-cystectomy pT0/pT1/pTa patients for the following variables: hydronephrosis, carcinoma in situ (CIS), lymphovascular invasion, history of non-muscular invasive disease, residual tumor in the specimen and lymphatic invasion (pN). pN+patients were excluded from definitive analysis. The quantitative and qualitative variables were analyzed using standard statistics. The chi-square test was used to analyze associations between categorical variables. Univariate Cox proportional hazard regression analysis (enter method) was performed. The Kaplan-Meier method was used to evaluate survival and the log-rank test to assess differences between groups. Statistical significance was set at p<0.05. The analysis was performed using SPSS version 15.0.
The study sample included 97 cases. The specimen was staged at T2 in 97% of patients after transurethral resection (TUR); After cystectomy, the specimen was staged as pT0 (R0) in 44.3% and pT1/Ta (R1) in 55.7%. Median follow-up was 47 months. Lymph node metastasis were detected in 5.2% of patients (pN+rpar; and had a negative impact on survival (p=0.02). Overall survival was 59.8% and cancer-specific survival 76.6%. Univariate analysis showed a relationship between tumor progression and the presence of CIS (p < 0.001), lymphovascular invasion (p=0.049), and hydronephrosis(p < 0.001). In the multivariate analysis, only the presence of CIS in the transurethral resection was associated with reduced cancer-specific survival (HR 100.5; 95% CI, 10.8 to 933.1; pp<0.001).
Although the prognosis of stage pT0/pT1/pTa carcinoma in the cystectomy specimen is excellent, some patients experience progression. The presence of CIS in the transurethral resection was an independent predictor of recurrence in these cases.
确定膀胱全切术后病理分期为pT0/pT1/pTa的浸润性膀胱癌患者病情进展的危险因素。
我们分析了97例膀胱全切术后pT0/pT1/pTa患者的临床记录,观察以下变量:肾积水、原位癌(CIS)、淋巴管浸润、非肌层浸润性疾病史、标本中的残留肿瘤以及淋巴结浸润(pN)。pN+患者被排除在最终分析之外。定量和定性变量采用标准统计学方法进行分析。卡方检验用于分析分类变量之间的关联。进行单因素Cox比例风险回归分析(逐步法)。采用Kaplan-Meier法评估生存率,对数秩检验评估组间差异。设定统计学显著性为p<0.05。使用SPSS 15.0版进行分析。
研究样本包括97例患者。经尿道切除(TUR)后,97%患者的标本分期为T2;膀胱全切术后,44.3%的标本分期为pT0(R0),55.7%为pT1/Ta(R1)。中位随访时间为47个月。5.2%的患者检测到淋巴结转移(pN+),对生存率有负面影响(p=0.02)。总生存率为59.8%,癌症特异性生存率为76.6%。单因素分析显示肿瘤进展与CIS的存在(p<0.001)、淋巴管浸润(p=0.049)和肾积水(p<0.